Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Christopher Kell

Treatment of Atopic Dermatitis With Tralokinumab, an Anti–IL-13 Monoclonal Antibody

Journal of Allergy and Clinical Immunology

English

A Phase 2b Dose-Ranging Efficacy and Safety Study of Tralokinumab in Adult Patients With Moderate to Severe Atopic Dermatitis

SKIN The Journal of Cutaneous Medicine

English

Related publications

Atopic Dermatitis Is an IL-13 Dominant Disease With Greater Molecular Heterogeneity Compared to Psoriasis

Journal of Investigative Dermatology

Molecular Biology

English

IL-13 Induces Skin Fibrosis in Atopic Dermatitis by Thymic Stromal Lymphopoietin

Journal of Immunology

English

Interleukin-13: Targeting an Underestimated Cytokine in Atopic Dermatitis

Allergy: European Journal of Allergy and Clinical Immunology

English

Orphan Designation: Humanised Anti-Il-6 Receptor Monoclonal Antibody, Treatment of Neuromyelitis Optica Spectrum Disorders

Case Medical Research

English

Histological and Immunohistological Findings Using Anti-Cortisol Antibody in Atopic Dermatitis With Topical Steroid Addiction

Dermatology and Therapy

English

IL-16 Serum Level in Children With Atopic Dermatitis

International Journal of Immunopathology and Pharmacology

English

Long-Term Delivery of an Anti-Siv Monoclonal Antibody With AAV

Frontiers in Immunology

English

Measurement of Total Serum IgE Antibody in Patients With Atopic Dermatitis

Annals of the College of Medicine, Mosul

English

560 KPL-716, Anti-Oncostatin M Receptor Beta Antibody, Reduced Pruritus in Atopic Dermatitis

Journal of Investigative Dermatology

Molecular Biology

English